United States Organ-on-a-Chip Market to Grow with a CAGR of 5.15% through 2030
Surge in
research and development activities is expected to drive the United States Organ-on-a-Chip
Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “United States Organ-on-a-Chip Market – By Region, Competition,
Forecast & Opportunities, 2030F”, the United States Organ-on-a-Chip
Market stood at USD 68.20 Million in 2024 and is anticipated to grow with a
CAGR of 5.15% through 2030. Initiatives taken by government based on organ-on-a-chip
has led to favorable market conditions for the United States Organ-on-a-Chip
Market. Several factors contribute to the growth of various organ-on-a-chip products.
One of the most
notable initiatives comes from the National Institutes of Health (NIH) through
its Tissue Chip for Drug Screening program, launched in collaboration with the
Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug
Administration (FDA). This program was designed to accelerate the development
of microphysiological systems capable of mimicking human organs, with the
ultimate goal of improving the prediction of drug safety and efficacy.
A significant driver of growth in the United States Organ-on-a-Chip market is the surge in research and development activities across the biotechnology, pharmaceutical, and academic sectors. As the demand for more accurate, human-relevant models in drug discovery and disease research intensifies, organizations are increasingly investing in advanced technologies that can replicate organ-level functions in vitro. Organ-on-a-Chip systems offer a promising solution by providing dynamic, microengineered environments that closely simulate human physiological conditions, allowing for more predictive and efficient preclinical testing.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "UnitedStates Organ-on-a-Chip Market”
The United
States Organ-on-a-Chip Market is segmented into device, application, regional
distribution, and company.
Based
on Device, Lung-on-a-Chip have emerged as the dominating segment in the United
States Organ-on-a-Chip Market in 2024. One of the key factors driving this
segment's dominance is the rising incidence of respiratory diseases such as
asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and
most recently, COVID-19. These conditions have highlighted the urgent need for
more accurate, human-relevant in vitro models to study lung function, disease
progression, and therapeutic response.
Based on Region,
Northeast have emerged as the fastest growing region in the United States Organ-on-a-Chip
Market in 2024. This region benefits from strong funding support from both
public agencies such as the NIH and private venture capital, which accelerates
the development and commercialization of advanced biomedical technologies like
Organ-on-a-Chip systems. Additionally, the Northeast's proximity to major
regulatory bodies and thought leaders in biomedical research provides a
strategic advantage in influencing and aligning with emerging standards and
regulatory pathways.
Major companies
operating in United States Organ-on-a-Chip Market are:
- Emulate, Inc.
- MIMETAS B.V.
- Valo Health
- Quris
Technologies LTD.
- AxoSim
- BICO - THE BIO
CONVERGENCE COMPANY
- CN Bio
Innovations Ltd
- The Charles
Stark Draper Laboratory, Inc.
- SynVivo, Inc.
- AlveoliX AG
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Nanotechnology
plays a critical role in advancing the United States Organ-on-a-Chip (OOC)
market by enhancing the precision, functionality, and scalability of OOC
platforms. Through the integration of nanoscale materials and engineering
techniques, researchers are able to replicate complex biological environments
with greater accuracy, closely mimicking human organ systems. Nanostructured
surfaces and nanoparticles improve cell adhesion, signaling, and tissue
interface, enabling more realistic simulation of physiological responses”, said
Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“United States
Organ-on-a-Chip Market By Device (Liver-on-a-Chip, Lung-on-a-Chip,
Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others), By Application
(Drug Discovery, Toxicology Research, Others), By Region and Competition,
Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of United States Organ-on-a-Chip Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United States Organ-on-a-Chip Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com